Investigation of the Effect of Vitamin K Prophylaxis on Newborn Screenings Tests in Newborns

Effect of Vitamin K on Newborn Screenings Tests

Keywords: Vitamin K, heel blood, hereditary disorders, tandem MS, interference, newborn

Abstract


Background: Routine screening for hereditary disorders in newborns includes screening for treatable metabolic and endocrine disorders, such as biotidinase deficiency, galactosemia, maple syrup urine disease, hypothyroidism, and cystic fibrosis. Incorrect test results may be encountered due to the use of vitamin K. To investigate the interference effect of vitamin K on neonatal screening tests and to raise awareness of erroneous measurements.

Methods: Heel blood samples were taken from 25 newborns born in a neonatal intensive care unit. Dry blood C0, C2, C3, C4, C4DC, C5:1, C5OH, C5DC, C6, C6DC, C8, C8:1, C8DC, C10, C10:1, C10DC, C12, C14, C14:1, C14:2, C16, C16:1, C18, C18:1, C18:2, C18:OH, methylglutaryl, valine, leucine/isoleucine, methionine, phenylalanine, argininosuccinic acid, aspartate, alanine, arginine, citrulline, glycine, ornithine, and glutamate tests were studied using the tandem mass spectrometry (MS) method. The results of the heel blood samples obtained before and after the application of vitamin K1 (Phyto menadione) were compared.

Results: In two studies conducted with in vitro and in vivo tests, C0, C2, C3, C4, C4DC, C5, C5OH, C6, C8, C10, C10:1, C14, C16, C16:1, C18, C18:1, methylglutaryl, phenylalanine, argininosuccinic acid, tyrosine, aspartate, arginine, citrulline, glycine, and glutamine were all significantly elevated (p < 0.05).

Conclusion: Heel blood samples may yield false results due to vitamin K administration. In the case of doubtful results, a new sample should be taken and the measurement should be repeated.

References

1. Rinaldo P, Matern D. Newborn screening for inherited metabolic disease. Inherited Metabolic Diseases: Springer, 2010: 251-61.
2. Millington D, Kodo N, Norwood D, Roe C. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 1990; 13(3): 321-24.
3. Wilcken B, Rinaldo P, Matern D. Newborn screening for inborn errors of metabolism. Inborn Metabolic Diseases: Springer 2012: 75-86.
4. Gross JH. Mass spectrometry: a textbook: Springer Science & Business Media; 2006.
5. Souverain S, Rudaz S, Veuthey JL. Matrix effect in LC-ESI-MS and LC-APCI-MS with off-line and on-line extraction procedures. J Chromatogr A 2004; 1058(1-2): 61-66.
6. la Marca G, Malvagia S, Pasquini E, Innocenti M, Fernandez MR, Donati MA, et al. The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs. Rapid Commun Mass Spectrom 2008; 22(6): 812-18.
7. Azzari C, la Marca G, Resti M. Neonatal screening for severe combined immunodeficiency caused by an adenosine deaminase defect: a reliable and inexpensive method using tandem mass spectrometry. J Allergy Clin Immunol 2011; 127(6): 1394-99.
8. Krasowski MD, Drees D, Morris CS, Maakestad J, Blau JL, Ekins S. Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction. BMC Clin Pathol 2014; 14:33.
9. Simpson J, Zhang Q, Ozaeta P, Aboleneen H. A specific method for the measurement of cyclosporin A in human whole blood by liquid chromatography-tandem mass spectrometry. Ther Drug Monit 1998; 20(3): 294-300.
10. Kang JS. Matrix effects: Hurdle for development and validation of bioanalytical LC-MS methods in biological samples analyses. J Biodesign 2016; 4(2): 46-58.
11. Samarasinghe S, Meah F, Singh V, Basit A, Emanuele N, Emanuele MA, et al. Biotin Interference with Routine Clinical Immunoassays: Understand the Causes and Mitigate the Risks. Endocr Pract 2017; 23(8): 989-98.
12. Colon PJ, Greene DN. Biotin Interference in Clinical Immunoassays. J Appl Lab Med 2018; 2(6): 941-51.
13. Chun KY. Biotin Interference in Diagnostic Tests. Clin Chem 2017; 63(2): 619-20.
14. Piketty ML, Prie D, Sedel F, Bernard D, Hercend C, Chanson P, et al. High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference. Clin Chem Lab Med 2017; 55(6): 817-25.
15. Bowen R, Benavides R, Colón-Franco JM, Katzman BM, Muthukumar A, Sadrzadeh H, et al. Best practices in mitigating the risk of biotin interference with laboratory testing. Clin Biochem 2019; 74: 1-11.
16. Mohamadi-Nejad A, Moosavi-Movahedi AA, Hakimelahi GH, Sheibani N. Thermodynamic analysis of human serum albumin interactions with glucose: insights into the diabetic range of glucose concentration. Int J Biochem Cell Biol 2002; 34(9): 1115-24.
17. Shimamura Y, Maeda T, Ogawa Y, Nagai Y, Shinohara T, Takizawa H. Unusual manifestation of monoclonal gammopathy of undetermined significance: a false serum creatinine elevation. CEN Case Rep 2020; 9(2): 109-13.
18. Tarini BA, Christakis DA, Welch HG. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results. Pediatrics 2006; 118(2): 448-56.
19. Kwon C, Farrell PM. The magnitude and challenge of false-positive newborn screening test results. Arch Pediatr Adolesc Med 2000; 154(7): 714-18.
20. Tarini BA, Clark SJ, Pilli S, Dombkowski KJ, Korzeniewski SJ, Gebremariam A, et al. False-positive newborn screening result and future health care use in a state Medicaid cohort. Pediatrics 2011; 128(4): 715-22.
21. Shard AG, Spencer SJ, Smith SA, Havelund R, Gilmore IS. The matrix effect in organic secondary ion mass spectrometry. Int J Mass Spectrom 2015; 377: 599-609.
22. Kruve A, Künnapas A, Herodes K, Leito I. Matrix effects in pesticide multi-residue analysis by liquid chromatography-mass spectrometry. J Chromatogr A 2008; 1187(1-2): 58-66.
23. Uclés S, Lozano A, Sosa A, Parrilla Vázquez P, Valverde A, Fernández-Alba AR. Matrix interference evaluation employing GC and LC coupled to triple quadrupole tandem mass spectrometry. Talanta 2017; 174: 72-81.
24. Martin K, Spickermann J, Räder HJ, Müllen K. Why does matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry give incorrect results for broad polymer distributions? Rapid Commun Mass Spectrom 1996; 10(12): 1471-74.
25. Cunniff JB, Vouros P. False positives and the detection of cyclodextrin inclusion complexes by electrospray mass spectrometry. J Am Soc Mass Spectrom 1995; 6(5): 437-47.
26. Rees JA, Deblonde GJ, An DD, Ansoborlo C, Gauny SS, Abergel RJ. Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents. Sci Rep 2018; 8(1): 4419.
27. Gonel A, Kirhan I, Koyuncu I, Bayraktar N, Karadag ME, Karadag M. The Role of Interferences in the Increasing Incidence of Vitamin D Deficiency. Endocr Metab Immune Disord Drug Targets 2020; 20(8): 1303-08.
28. Pehlivan VF, Gönel A, Pehlivan B, Koyuncu I. False Laboratory Test Result Through Colistin Interference in an Intensive Care Patient: Case Report. Comb Chem High Throughput Screen 2020; 23(8): 827-31.
29. Tascanov MB, Gönel A. How Do Contrast Agents Affect Cardiac Markers and Coagulation Tests? Experimental Study. Comb Chem High Throughput Screen. 2019; 22(5): 355-60.
Published
2023/08/13
Section
Original paper